LEFLUNOMIDE APOTEX leflunomide 20mg tablets blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

leflunomide, Quantity: 20 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Leflunomide

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; lactose

Verabreichungsweg:

Oral

Einheiten im Paket:

30 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

LEFLUNOMIDE APOTEX is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. GenRx Leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. The combined use of GenRx Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Produktbesonderheiten:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2008-07-14